Evidence map›Paper›PMID 24814316›Full record

ArticleDevelopmental cell2014

Tensin-4-dependent MET stabilization is essential for survival and proliferation in carcinoma cells.

Ghaffar Muharram, Pranshu Sahgal, Taina Korpela, Nicola De Franceschi, Riina Kaukonen, Katherine Clark, David Tulasne, Olli Carpén, Johanna Ivaska

Erratum issuedOpen access · hybridAbstract read
In one paragraph

Article in Developmental cell, 2014. The graph could read no effect estimate from its abstract, so it casts no vote on the map. An erratum has been issued. Cited by 34 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
34citing papers in PubMed, 1 pooled it
2.7field-weighted citation impact, top 9% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

34 citing papers in PubMed, 1 synthesis or guideline pooled it, 87 citations in OpenAlex.

  1. Pooled it
  2. Article
  3. Article
  4. Review
  5. The MET Oncogene: An Update on Targeting Strategies.Pharmaceuticals (Basel, Switzerland) · 2024
    Review
  6. Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. Review
  12. Article
  13. Article
  14. Article
  15. Review
  16. Article
  17. Article
  18. Article
  19. Article
  20. The Journal of neuroscience : the official journal of the Society for Neuroscience · 2019
    Article
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

9 authors at 5 institutions in 3 countries.

Ghaffar MuharramTurku Centre for Biotechnology, University of Turku, Turku, 20520, Finland; VTT Technical Research Centre of Finland, Turku, 20521, Finland.
Pranshu SahgalTurku Centre for Biotechnology, University of Turku, Turku, 20520, Finland; VTT Technical Research Centre of Finland, Turku, 20521, Finland.
Taina KorpelaDepartment of Pathology, University of Turku, Turku, 20520, Finland; Department of Pathology, Turku University Hospital, Turku, 20520, Finland.
Nicola De FranceschiTurku Centre for Biotechnology, University of Turku, Turku, 20520, Finland; VTT Technical Research Centre of Finland, Turku, 20521, Finland.
Riina KaukonenTurku Centre for Biotechnology, University of Turku, Turku, 20520, Finland; VTT Technical Research Centre of Finland, Turku, 20521, Finland.
Katherine ClarkDepartment of Biochemistry, University of Leicester, Leicester LE1 9HN, UK.
David TulasneInstitut de Biologie de Lille-UMR8161, CNRS, 59021 Lille, France.
Olli CarpénDepartment of Pathology, University of Turku, Turku, 20520, Finland; Department of Pathology, Turku University Hospital, Turku, 20520, Finland.
Johanna IvaskaTurku Centre for Biotechnology, University of Turku, Turku, 20520, Finland; VTT Technical Research Centre of Finland, Turku, 20521, Finland; Department of Biochemistry and Food Chemistry, University of Turku, 20520, Finland. Electronic address: johanna.ivaska@utu.fi.
Turku Centre for Biotechnology · FITurku University Hospital · FICentre National de la Recherche Scientifique · FRUniversity of Leicester · GBVTT Technical Research Centre of Finland · FI

Funding

European Research Council 202809European Research Council 615258Wellcome Trust
6 · The paper itself

Abstract

Inappropriate MET tyrosine kinase receptor signaling is detected in almost all types of human cancer and contributes to malignant growth and MET dependency via proliferative and antiapoptotic activities. Independently, Tensin-4 (TNS4) is emerging as a putative oncogene in many cancer types, but the mechanisms of TNS4 oncogenic activity are not well established. Here, we demonstrate that TNS4 directly interacts with phosphorylated MET via the TNS4 SH2-domain to positively regulate cell survival, proliferation, and migration, through increased MET protein stability. In addition, TNS4 interaction with β1-integrin cytoplasmic tail positively regulates β1-integrin stability. Loss of TNS4 or disruption of MET-TNS4 interaction triggers MET trafficking toward the lysosomal compartment that is associated with excessive degradation of MET and triggers MET-addicted carcinoma cell death in vitro and in vivo. Significant correlation between MET and TNS4 expression in human colon carcinoma and ovarian carcinoma suggests TNS4 plays a critical role in MET stability in cancer.

Indexed as

AnimalsBinding SitesCarcinomaCell AdhesionCell Line, TumorCell MovementCell ProliferationCell SurvivalColonic NeoplasmsEndocytosisFemaleHEK293 CellsHepatocyte Growth FactorHumansIntegrin beta1MiceHepatocyte Growth FactorIntegrin beta1MET protein, humanMicrofilament ProteinsProto-Oncogene Proteins c-metRNA, Small InterferingTensinsTNS4 protein, humanTns4 protein, mouse

Identifiers

PMID24814316
PMCPMC4118019
OpenAlexW2030958037

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.